RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Alembic Pharmaceuticals Equity 2024

Alembic Pharmaceuticals Equity

43.7 B INR

Alembic Pharmaceuticals Dividend yield

0.85 %

Ticker

APLLTD.NS

ISIN

INE901L01018

In 2024, Alembic Pharmaceuticals's equity was 43.7 B INR, a -16.56% increase from the 52.38 B INR equity in the previous year.

Alembic Pharmaceuticals Aktienanalyse

What does Alembic Pharmaceuticals do?

Alembic Pharmaceuticals Ltd is an Indian pharmaceutical company that was founded in 1907 and is headquartered in Vadodara, Gujarat, India. It is one of the leading pharmaceutical companies in India and has also gained recognition internationally in recent years. Its products include medications used in the fields of dermatology, neurology, cardiology, gynecology, oncology, and ophthalmology. The business model of Alembic Pharmaceuticals Ltd is based on a vertically integrated approach. This means that the company maintains control over the entire value chain, from research and development to production, distribution, and marketing. This strategy allows the company to respond quickly and effectively to changes in the markets and offer its products at a competitive price. One of the key divisions of Alembic Pharmaceuticals Ltd is research and development. The company has a strong team of scientists and researchers who work on developing innovative products for the Indian and international markets. Key projects include medications for the treatment of cancer, neurological disorders, and infections. The company also has a strong presence in India and serves the domestic market with a wide range of generics and branded medications. Some of its well-known products include Oleptal, Oleset, and Zanocin. These medications are offered in various forms such as tablets, capsules, and injection solutions to meet the needs of patients. Alembic Pharmaceuticals Ltd also has a strong presence in the international market, particularly in the United States and Europe. The company has various joint ventures and partnerships with international pharmaceutical companies such as Sun Pharma, Pfizer, Novartis, and Teva Pharmaceuticals. These partnerships enable the company to bring its products to the global market and expand its portfolio. Alembic Pharmaceuticals Ltd is also involved in the development and manufacturing of active pharmaceutical ingredients and intermediates. The company produces and distributes various active pharmaceutical ingredients, including APIs for use in the manufacturing of generics and branded medications. The company has received various awards and recognition in recent years. In 2020, it was included in Fortune India's list of top 500 companies in India. The company also received the Frost & Sullivan 2020 Global Pharmaceutical Company of the Year Award and was included in Forbes Asia's list of the top 200 companies in Asia in 2019. Overall, Alembic Pharmaceuticals Ltd is a significant company in the pharmaceutical industry in India and internationally. The company is committed to further developing and expanding its position as a leading pharmaceutical company. Alembic Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Alembic Pharmaceuticals's Equity

Alembic Pharmaceuticals's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Alembic Pharmaceuticals's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Alembic Pharmaceuticals's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Alembic Pharmaceuticals's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Alembic Pharmaceuticals’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Alembic Pharmaceuticals Stock

What is the equity of Alembic Pharmaceuticals this year?

Alembic Pharmaceuticals has equity of 43.7 B INR this year.

What was the equity of Alembic Pharmaceuticals compared to the previous year?

The equity of Alembic Pharmaceuticals has increased/decreased by -16.56% decreased compared to the previous year.

What impact does a high equity have on investors of Alembic Pharmaceuticals?

A high equity is advantageous for investors of Alembic Pharmaceuticals as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Alembic Pharmaceuticals?

A low equity can be a risk for investors of Alembic Pharmaceuticals, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Alembic Pharmaceuticals affect the company?

An increase in equity of Alembic Pharmaceuticals can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Alembic Pharmaceuticals affect the company?

A reduction in equity of Alembic Pharmaceuticals can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Alembic Pharmaceuticals?

Some factors that can affect the equity of Alembic Pharmaceuticals include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Alembic Pharmaceuticals so important for investors?

The equity of Alembic Pharmaceuticals is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Alembic Pharmaceuticals take to change the equity?

To change equity, Alembic Pharmaceuticals can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Alembic Pharmaceuticals pay?

Over the past 12 months, Alembic Pharmaceuticals paid a dividend of 8 INR . This corresponds to a dividend yield of about 0.85 %. For the coming 12 months, Alembic Pharmaceuticals is expected to pay a dividend of 8.55 INR.

What is the dividend yield of Alembic Pharmaceuticals?

The current dividend yield of Alembic Pharmaceuticals is 0.85 %.

When does Alembic Pharmaceuticals pay dividends?

Alembic Pharmaceuticals pays a quarterly dividend. This is distributed in the months of May, August, October, August.

How secure is the dividend of Alembic Pharmaceuticals?

Alembic Pharmaceuticals paid dividends every year for the past 16 years.

What is the dividend of Alembic Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 8.55 INR are expected. This corresponds to a dividend yield of 0.91 %.

In which sector is Alembic Pharmaceuticals located?

Alembic Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Alembic Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Alembic Pharmaceuticals from 8/8/2023 amounting to 8 INR, you needed to have the stock in your portfolio before the ex-date on 7/28/2023.

When did Alembic Pharmaceuticals pay the last dividend?

The last dividend was paid out on 8/8/2023.

What was the dividend of Alembic Pharmaceuticals in the year 2023?

In the year 2023, Alembic Pharmaceuticals distributed 10 INR as dividends.

In which currency does Alembic Pharmaceuticals pay out the dividend?

The dividends of Alembic Pharmaceuticals are distributed in INR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Alembic Pharmaceuticals

Our stock analysis for Alembic Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Alembic Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.